New diagnostic criteria for alcohol use disorders and novel treatment approaches - 2014 update

Archives of Medical Science

Volumn 10, Issue 6, 2014, Pages 1191-1197

  Tyburski, Ernest M ^a   Sokolowski, Andrzej ^b   Samochowiec, Jerzy ^c   Samochowiec, Agnieszka ^a,c  

^a UNIVERSITY OF SZCZECIN   (Poland)

^b ADAM MICKIEWICZ UNIVERSITY   (Poland)

^c POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Alcohol use disorder; DSM 5; Genetic risk; Harm reduction; ICD 11

Indexed keywords

ABSTINENCE; ALCOHOL USE DISORDER; ALCOHOLISM; ARTICLE; DISEASE CLASSIFICATION; DSM-IV; HUMAN; ICD-11; PERSONALITY; PRACTICE GUIDELINE; RISK FACTOR;

EID: 84919966770     PISSN: 17341922     EISSN: 18969151     Source Type: Journal    
DOI: 10.5114/aoms.2014.47829     Document Type: Article

References (66)

1. Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009; 373: 2223-33.
2. Limosin F. Epidemiologic warnings from studies on alcohol use disorders. Encephale 2014; 40: 129-35.
3. World Health Organization. Library Cataloguing-in-Pub-lication Data. Geneva, WHO 2011.
4. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007; 64: 830-42.
5. Grant BF, Dawson DA, Stinson FS, Chou SP, Dufour MC, Pickering RP. The 12-month prevalence and trends in DSM-IV alcohol abuse and dependence: United states, 1991-1992 and 2001-2002. Drug Alcohol Depend 2004; 74: 223-34.
6. http://www.samhsa.gov/data/NSDUH/2012SummNat-FindDetTables/DetTabs/NSDUH-DetTabsSect5peTab-s1to56-2012.htm#Tab5.8A
7. http://www.parpa.pl/index.php?option=com-con-tent&task=view&=155&Itemid=16
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). APA, Wahs-ington: 2013.
9. Heitzman J, Łoza B, Kosmowski W. Classifcation of mental disorders-a conceptual framework for the ICD-11. Psychiatr Pol 2011; 45: 941-50.
10. Jakubczyk A, Wojnar M. Total abstinence or harm reduction-diferent strategies of alcohol treatment in research studies and international guidelines. Psychiatr Pol 2012; 46: 373-86.
11. Łoza B, Heitzman J, Kosmowski W. Toward the new classifcation of mental disorders-Polish psychiatrists' opinions about project of ICD-11. Psychiatr Pol 2011; 45: 785-98.
12. http://apps.who.int/classifcations/icd11/browse/f/en
13. Saunders JB. Substance dependence and non-dependence in the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classifcation of Diseases (ICD): can an identical conceptualization be achieved? Addiction 2006; 101: 48-58.
14. Hasin D, Hatzenbuehler ML, Keyes K, Ogburn E. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classifcation of Diseases, tenth edition (ICD-10). Addiction 2006; 101: 59-75.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). APA, Washington 1994.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM III). APA, Washington 1987.
17. Kałwa A. Impulsivity and decision making in alcohol-addicted individuals. Psychiatr Pol 2013; 47: 325-34.
18. Buscemi L, Turchi C. An overview of the genetic susceptibility to alcoholism. Med Sci Law 2011; 51: 2-6.
19. Dragan WŁ, Oniszczenko W, Czerski PM, Dmitrzak-We-glarz M. Family-based association study of dopami-nergic genes polymorphisms and EAS temperamental traits. Psychiatr Pol 2013; 47: 185-95.
20. Augustyńska B, Araszkiewicz A, Wozniak A, et al. The assessment of metabolism of bone tissue as changes in concentration of biochemical markers of bone turnover in inpatient alcohol dependent women. Psychiatr Pol 2013; 47: 17-30.
21. Bieńkowski P. Pharmacological features of naltrexone and its use in the treatment of alcohol dependence. Psychiatr Pol 2013; 47: 117-26.
22. Jasiewicz A, Grzywacz A, Jabłoński M, Bieńkowski P, Samochowiec A, Samochowiec J. The analysis of the polymorphic variations of the dopamine gen transporter (DAT1) and the serotonin transporter (5-HTTLPR) in patients with alcohol dependence syndrome with inclusion of the phenotypic feature of sweet liking preference. Psychiatr Pol 2014; 48: 89-103.
23. Samochowiec A, Mordasewicz A, Arentowicz G, Samo-chowiec J. Addiction pathogenesis in genetic research. Psychiatria 2005; 2: 9-18.
24. Sigvardsson S, Bohman M, Cloninger CR. Replication of the stockholm adoption study of alcoholism. Confrma-tory cross-fostering analysis. Arch Gen Psychiatry 1996; 53: 681-7.
25. Prescott CA, Kendler KS. Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry 1999; 156: 34-40.
26. Samochowiec A, Horodnicki JM, Samochowiec J. The infuence of parents personality and DRD4 and 5HTT genes polymorphisms on predisposition to alcohol dependence in their sons. Psychiatr Pol 2011; 45: 337-47.
27. Murphy JM, Stewart RB, Bell RL, et al. Phenotypic and genotypic characterization of the indiana university rat lines selectively bred for high and low alcohol preference. Behav Genet 2002; 32: 363-88.
28. Chamorro AJ, Marcos M, Miron-Canelo JA, Pastor I, Gon-zalez-Sarmiento R, Laso FJ. Association of micro-opioid receptor (oprm1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis. Addict Biol 2012; 17: 505-12.
29. Edenberg HJ. The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants. Alcohol Res Health 2007; 30: 5-13.
30. Chen XD, Xiong DH, Yang TI, et al. Ankrd7 and cytl1 are novel risk genes for alcohol drinking behavior. Chin Med J 2012; 125: 1127-34.
31. Frank J, Cichon S, Treutlein J, et al. Genome-wide sig-nifcant association between alcohol dependence and a variant in the adh gene cluster. Addict Biol 2012; 17: 171-80.
32. Grochans E, Grzywacz A, Małecka I, Samochowiec A, Karakiewicz B, Samochowiec J. Research on associations between selected polymorphisms of genes DRD2, 5HTT, GRIK3, ADH4 and alcohol dependence syndrome. Psychiatr Pol 2011; 45: 325-35.
33. Błachut M, Badura-Brzoza K, Jarzab M, Gorczyca P, Hese RT. Dual diagnosis in psychoactive substance abusing or dependent persons. Psychiatr Pol 2013; 47: 335-52.
34. Szewczuk-Bogusławska M, Flisiak-Antonijczuk H. Will new diagnostic criteria facilitate the diagnostic process of ADHD in adults? Psychiatr Pol 2013; 47: 293-302.
35. Kendler KS, Gardner C, Dick DM. Predicting alcohol consumption in adolescence from alcohol-specifc and general externalizing genetic risk factors, key environmental exposures and their interaction. Psychol Med 2011; 41: 1507-16.
36. Young-Wolf KC, Enoch MA, Prescott CA. The infuence of gene-environment interactions on alcohol consumption and alcohol use disorders: a comprehensive review. Clin Psychol Rev 2011; 31: 800-16.
37. Dick DM, Rose RJ, Viken RJ, Kaprio J, Koskenvuo M. Exploring gene-environment interactions: socioregional moderation of alcohol use. J Abnorm Psychol 2001; 110: 625-32.
38. Legrand LN, Keyes M, McGue M, Iacono WG, Krue ger RF. Rural environments reduce the genetic infuence on adolescent substance use and rule-breaking behavior. Psychol Med 2008; 38: 1341-50.
39. Dawson DA, Grant BF, Li TK. Quantifying the risks associated with exceeding recommended drinking limits. Alcohol Clin Exp Res 2005; 29: 902-8.
40. Kalinowska S, Trzes̈niowska-Drukała B, Samochowiec J. HIV-associated neurocognitive disorders. Psychiatr Pol 2013; 47: 453-63.
41. Simonienko K, Waszkiewicz N, Szulc A. Psychoactive plant species-actual list of plants prohibited in Poland. Psychiatr Pol 2013; 47: 499-510.
42. Riley D, Sawka E, Conley P, et al. Harm reduction: concepts and practice. A policy discussion paper. Subst Use Misuse 1999; 34: 9-24.
43. Marlatt GA, Witkiewitz K. Harm reduction approaches to alcohol use: health promotion, prevention, and treatment. Addict Behav 2002; 27: 867-86.
44. Marlatt GA. Harm reduction: come as you are. Addict Behav 1996; 21: 779-88.
45. Tyszkowska M, Magdalena P. Stigmatization on the way to recovery in mental illness-the factors directly linked to psychiatric therapy. Psychiatr Pol 2013; 47: 1011-22.
46. Rehm J, Zatoński W, Taylor B, Anderson P. Epidemiology and alcohol policy in Europe. Addiction 2011; 106: 11-9.
47. Ambrogne JA. Reduced-risk drinking as a treatment goal: what clinicians need to know. J Subst Abuse Treat 2002; 22: 45-53.
48. Mazurkiewicz MR, Głogowski M, Mrowińska D, Pakul-ski M, Matyjaszczyk M, Kardas P. Prevalence, reasons, and forms of use of legal highs by internet-based survey participants. Psychiatr Pol 2013; 47: 1143-55.
49. Lesch OM, Kefer J, Lentner S, et al. Diagnosis of chronic alcoholism-classifcatory problems. Psychopathology 1990; 23: 88-96.
50. Schlaf GW, Lesch OM. The Lesch alcoholism typology-psychiatric and psychosocial treatment approaches. Ann Gastroenterol 2011; 24: 89-97.
51. Jarema M. Standards of pharmacological treatment of some psychiatric disorders. Via Medica, Gdansk 2011.
52. Bieńkowski P, Habrat B, Jarema M, et al. Long-term pharmacotherapy aimed at maintaining abstinence or reducing alcohol intake in alcohol-dependent individuals. Guidelines of the Pharmacotherapy Section of the Polish Society for Research on Addictions (PTBU) and the Psychopharmacology Section of the Polish Psychiatric Association (PTP). Farmakoter Psychiatr Neurol 2013; 34: 133-9.
53. Betkowska-Korpała B. Personality in the big fve model and maintaining abstinence after one year follow-up. Psychiatr Pol 2012; 46: 387-99.
54. Charzyńska K, Sawicka M, Osuchowska A, et al. Socio-demographic and clinical profle of patients with dual diagnosis living in Warsaw district Mokotow in comparison with participants in other European countries-results of the international, multicentre research project ISADORA. Psychiatr Pol 2013; 4: 989-1000.
55. Li TK, Hewitt BG, Grant BF. The alcohol dependence syndrome, 30 years later: a commentary. the 2006 H. David Archibald lecture. Addiction 2007; 102: 1522-30.
56. NICE, National Institute for Health and Clinical Excellence. Alcohol dependence and harmful alcohol use (CG115). National Institute for Health and Clinical Excellence, London 2011.
57. Lingford-Hughes AR, Welch S, Peters L, Nutt DJ. British Association for Psychopharmacology, Expert Reviewers Group. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol 2012; 26: 899-952.
58. Jabłoński M, Jasiewicz A, Kucharska-Mazur J, et al. The efect of selected polymorphisms of the dopamine receptor gene DRD2 and the ANKK-1 on the preference of concentrations of sucrose solutions in men with alcohol dependence. Psychiatr Danub 2013; 25: 371-8.
59. Antosik-Wójcińska AZ, Bodzak-Opolska G. Analgesics in the population of people over 65 years old. Psychiatry 2013; 10: 139-43.
60. Vetulani J. Neurochemistry of impulsiveness and aggression. Psychiatr Pol 2013; 47: 103-15.
61. Deksnyte A, Aranauskas R, Kasiulevičius V, Šapoka V, Palinauskaite K, Gaidamowicz R. Parameters of ante-mortem delirium. Psychiatr Pol 2014; 48: 145-55.
62. Romanowicz-Makowska H, Smolarz B, Gajęcka M, et al. Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking-and drinking-related laryngeal cancer in a Polish population. Arch Med Sci 2012; 8: 1065-75.
63. Khan TM, Sulaiman SA, Hassali MA. Factors associated with suicidal behaviour among depressed patients in Penang, Malaysia. Arch Med Sci 2012; 8: 697-703.
64. Gorzkowska I, Gorzkowski G, Samochowiec A, Sucha-necka A, Samochowiec J. An interaction between a polymorphism of the serotonin transporter (5HTT) gene and the clinical picture of adolescents with combined type of ADHD (hyperkinetic disorder) and youth drinking. Psychiatr Pol 2014; 49: 541-51.
65. Styła R. Diferences in efectiveness of intensive programs of treatment for neurotic and personality disorders. Is it worth to monitor the efectiveness of the therapeutic team? Psychiatr Pol 2014; 48: 157-71.
66. Samochowiec J, Samochowiec A, Puls I, Bienkowski P, Schott BH. Genetics of alcohol dependence: a review of clinical studies. Neuropsychobiology 2014; 70: 77-94.